Compounding pharmacy coverage in Maryland: shipping and rules for clinics

AffinityRx coverage in Maryland

AffinityRx covers Maryland for most SKUs (all 50 states for most SKUs) and checks state-board eligibility for you, including nonresident licensure and sterile permits. No state is unserved; if a specific medication is not available in Maryland, AffinityRx prioritizes sourcing a pharmacy that fills it there.

Read more about 50-state coverage and how AffinityRx checks it, or see how AffinityRx compares with other compounding pharmacy marketplaces.

Compounding pharmacies on AffinityRx that ship to Maryland

6 pharmacies on AffinityRx ship to Maryland. "License verified" means AffinityRx matched a MD license to a public board record; "Pharmacy-stated" means the pharmacy lists Maryland among its shipping states and AffinityRx has not yet matched a MD license record.

ProCompounding Pharmacy

Johnson City, TN

503ALicense verified

View profile

Promise Pharmacy

Palm Harbor, FL

503ALicense verified

View profile

Empower Pharmacy

Houston, TX

503A + 503BPharmacy-stated

View profile

Epiq Scripts

Richardson, TX

503APharmacy-stated

View profile

Revive Rx

Houston, TX

503APharmacy-stated

View profile

Valiant Pharmacy

Ypsilanti, MI

503APharmacy-stated

View profile

Compounded medications for Maryland clinics

AffinityRx pharmacies that ship to Maryland list these compounded medications with clinic prices (October 2026):

• Anastrozole from $0.90
• Lipotropic MIC + B12 from $75
• NAD+ from $55
• Sermorelin from $60
• Clomiphene citrate from $0.96
• Enclomiphene citrate from $1.35
• Glutathione from $30
• Semaglutide from $70
• Tadalafil from $25
• Tirzepatide from $120
• Methylcobalamin / Vitamin B12 from $80

Maryland compounding pharmacy FAQ

Maryland compounding pharmacy rules for clinics

The Maryland Board of Pharmacy requires a nonresident pharmacy license for out-of-state pharmacies shipping into Maryland.

Licensing and compounding rules

• Nonresident pharmacies need a Maryland nonresident pharmacy permit (COMAR 10.34.37); a recent inspection report is required, plus a sterile inspection report for sterile compounders.
• Maryland repealed its separate sterile compounding permit; nonresidents shipping compounded sterile preparations must instead comply with USP 797 and COMAR 10.34.19 as a condition of the pharmacy permit.

Federal baseline: office-use stock without a patient-specific prescription is lawful only from 503B outsourcing facilities, regardless of what a state allows. AffinityRx does not support office-use or clinic-stock ordering yet: ordering is patient-specific today, and office-use ordering arrives with 503B outsourcing facilities in Q4 2026–Q1 2027. Rules summarize the sources listed below and can change; verify with the board.

Sources

1. https://regs.maryland.gov/us/md/exec/comar/10.34.37.04
2. https://health.maryland.gov/pharmacy/docs/All%20BOP%20Forms/Licensing%20Forms/Pharmacy%20Forms%20-%20Fillable%20PDFs/2025/Nonresident_Pharmacy_Application%2004.07.2025.pdf
3. https://mgaleg.maryland.gov/2015RS/fnotes/bil_0009/sb0069.pdf

What Maryland clinics should verify before ordering

Before a Maryland clinic orders compounded medication, verify the items below. AffinityRx also checks shipping-state eligibility on every order.

• Confirm the pharmacy holds an active Maryland nonresident pharmacy license using the Maryland Board of Pharmacy lookup.
• Maryland does not require a separate nonresident sterile permit per the sources on file; still confirm sterile compounding licensure in the pharmacy's home state.
• Check the pharmacy's regulatory history, including FDA warning letters and state board actions, on its AffinityRx profile.

Compounding pharmacy rules in states near Maryland

Clinics serving patients across state lines should also check the rules in neighboring states.